Jeong Su Park

1.3k total citations
37 papers, 907 citations indexed

About

Jeong Su Park is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Jeong Su Park has authored 37 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 16 papers in Epidemiology and 8 papers in Oncology. Recurrent topics in Jeong Su Park's work include Genomics, phytochemicals, and oxidative stress (10 papers), Liver Disease Diagnosis and Treatment (7 papers) and Autophagy in Disease and Therapy (6 papers). Jeong Su Park is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (10 papers), Liver Disease Diagnosis and Treatment (7 papers) and Autophagy in Disease and Therapy (6 papers). Jeong Su Park collaborates with scholars based in South Korea, United States and Czechia. Jeong Su Park's co-authors include Soo Han Bae, Da Hyun Lee, Yu Seol Lee, Young Yang, Yong‐ho Lee, Ae Lee Jeong, Dong Hoon Kang, Sora Han, Sunyi Lee and Jong‐Seok Lim and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Immunology.

In The Last Decade

Jeong Su Park

37 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeong Su Park South Korea 19 440 315 164 102 101 37 907
Alessandra Dicitore Italy 16 458 1.0× 218 0.7× 294 1.8× 81 0.8× 65 0.6× 46 922
Zhengzhe Li China 19 471 1.1× 160 0.5× 117 0.7× 78 0.8× 77 0.8× 33 1.1k
Xiao Jia China 15 317 0.7× 186 0.6× 106 0.6× 78 0.8× 110 1.1× 25 996
Bilon Khambu United States 17 380 0.9× 607 1.9× 81 0.5× 152 1.5× 148 1.5× 36 1.1k
Lu Gao China 20 599 1.4× 171 0.5× 191 1.2× 70 0.7× 90 0.9× 63 1.2k
Lei Pei China 18 505 1.1× 173 0.5× 97 0.6× 43 0.4× 116 1.1× 55 1.1k
Mengmeng Li China 14 504 1.1× 494 1.6× 78 0.5× 189 1.9× 101 1.0× 32 1.2k
Monowarul Mobin Siddique Singapore 12 704 1.6× 426 1.4× 264 1.6× 159 1.6× 216 2.1× 19 1.3k
Takuya Mori Japan 20 314 0.7× 223 0.7× 93 0.6× 52 0.5× 182 1.8× 51 894
Xiaolong Lin China 20 567 1.3× 212 0.7× 83 0.5× 57 0.6× 77 0.8× 28 988

Countries citing papers authored by Jeong Su Park

Since Specialization
Citations

This map shows the geographic impact of Jeong Su Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeong Su Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeong Su Park more than expected).

Fields of papers citing papers by Jeong Su Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeong Su Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeong Su Park. The network helps show where Jeong Su Park may publish in the future.

Co-authorship network of co-authors of Jeong Su Park

This figure shows the co-authorship network connecting the top 25 collaborators of Jeong Su Park. A scholar is included among the top collaborators of Jeong Su Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeong Su Park. Jeong Su Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Jeong Su, M CHO, J. W. Kim, et al.. (2024). Chip collection of hepatocellular carcinoma based on O2 heterogeneity from patient tissue. Nature Communications. 15(1). 5117–5117. 3 indexed citations
2.
Lee, Chan Ho, Jisu Han, Ju Hye Shin, et al.. (2024). Repositioning of ezetimibe for the treatment of idiopathic pulmonary fibrosis. European Respiratory Journal. 63(5). 2300580–2300580. 5 indexed citations
3.
Lee, Da Hyun, Jeong Su Park, Yu Seol Lee, & Soo Han Bae. (2022). PERK prevents hepatic lipotoxicity by activating the p62-ULK1 axis-mediated noncanonical KEAP1-Nrf2 pathway. Redox Biology. 50. 102235–102235. 29 indexed citations
4.
Kim, Eun Ran, Jeong Su Park, Jin Hee Kim, et al.. (2021). A GLP‐1/GLP‐2 receptor dual agonist to treat NASH: Targeting the gut‐liver axis and microbiome. Hepatology. 75(6). 1523–1538. 55 indexed citations
5.
Lee, Da Hyun, Buhyun Lee, Jeong Su Park, et al.. (2019). Inactivation of Sirtuin2 protects mice from acetaminophen-induced liver injury: possible involvement of ER stress and S6K1 activation. BMB Reports. 52(3). 190–195. 16 indexed citations
6.
Lee, Jung Bok, Jeong Su Park, Young Min Shin, et al.. (2019). Implantable Vascularized Liver Chip for Cross‐Validation of Disease Treatment with Animal Model. Advanced Functional Materials. 29(23). 32 indexed citations
7.
Park, Jeong Su, Yu Seol Lee, Da Hyun Lee, & Soo Han Bae. (2019). Repositioning of niclosamide ethanolamine (NEN), an anthelmintic drug, for the treatment of lipotoxicity. Free Radical Biology and Medicine. 137. 143–157. 17 indexed citations
8.
Lee, Yu Seol, Jeong Su Park, Da Hyun Lee, et al.. (2018). The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition. Frontiers in Endocrinology. 9. 539–539. 8 indexed citations
9.
Park, Jeong Su, Ae Lee Jeong, Sora Han, et al.. (2017). Von Hippel-Lindau regulates interleukin-32β stability in ovarian cancer cells. Oncotarget. 8(41). 69833–69846. 6 indexed citations
10.
Jeong, Ae Lee, Sora Han, Sunyi Lee, et al.. (2016). Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway. Scientific Reports. 6(1). 27391–27391. 27 indexed citations
11.
Lee, Sunyi, Ae Lee Jeong, Jeong Su Park, et al.. (2016). IK-guided PP2A suppresses Aurora B activity in the interphase of tumor cells. Cellular and Molecular Life Sciences. 73(17). 3375–3386. 4 indexed citations
12.
Park, Jeong Su, Dong Hoon Kang, Da Hyun Lee, & Soo Han Bae. (2015). PF-4708671, a specific inhibitor of p70 ribosomal S6 kinase 1, activates Nrf2 by promoting p62-dependent autophagic degradation of Keap1. Biochemical and Biophysical Research Communications. 466(3). 499–504. 16 indexed citations
13.
Park, Jeong Su, Dong Hoon Kang, Da Hyun Lee, & Soo Han Bae. (2015). Fenofibrate activates Nrf2 through p62-dependent Keap1 degradation. Biochemical and Biophysical Research Communications. 465(3). 542–547. 31 indexed citations
14.
Han, Sora, Jeong Su Park, Sunyi Lee, et al.. (2015). CTRP1 protects against diet-induced hyperglycemia by enhancing glycolysis and fatty acid oxidation. The Journal of Nutritional Biochemistry. 27. 43–52. 35 indexed citations
15.
Park, Jeong Su, Dong Hoon Kang, Da Hyun Lee, & Soo Han Bae. (2015). Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity. Biochemical and Biophysical Research Communications. 466(1). 131–137. 30 indexed citations
16.
Park, Jeong Su, Dong Hoon Kang, & Soo Han Bae. (2015). p62 prevents carbonyl cyanide m-chlorophenyl hydrazine (CCCP)-induced apoptotic cell death by activating Nrf2. Biochemical and Biophysical Research Communications. 464(4). 1139–1144. 22 indexed citations
17.
Chang, Jeonghyun, et al.. (2014). Impact of monitoring blood volume in the BD BACTEC™ FX blood culture system: virtual volume versus actual volume. Diagnostic Microbiology and Infectious Disease. 81(2). 89–93. 18 indexed citations
18.
Choi, Yeon A., et al.. (2013). Estradiol enhances CIP2A expression by the activation of p70 S6 kinase. Endocrine Related Cancer. 21(2). 189–202. 14 indexed citations
19.
20.
Park, Jeong Su, Maria Lee, Eun Sook Nam, et al.. (2013). Interleukin-32β stimulates migration of MDA-MB-231 and MCF-7cells via the VEGF-STAT3 signaling pathway. Cellular Oncology. 36(6). 493–503. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandra Dicitore Breakdown of academic impact, for papers by Zhengzhe Li Breakdown of academic impact, for papers by Xiao Jia Breakdown of academic impact, for papers by Bilon Khambu Breakdown of academic impact, for papers by Lu Gao Breakdown of academic impact, for papers by Lei Pei Breakdown of academic impact, for papers by Mengmeng Li Breakdown of academic impact, for papers by Monowarul Mobin Siddique Breakdown of academic impact, for papers by Takuya Mori Breakdown of academic impact, for papers by Xiaolong Lin
Rankless by CCL
2026